رجوع
نطاق اليوم
KWD 1.67
KWD 1.72
نطاق 52 أسبوعًا
KWD 1.24
KWD 3.34
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 1.92
/
KWD 2.04
الإغلاق السابق
KWD 1.53
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -11.1 | 0.4 |
| P/B | 3.5 | 2.9 |
| ROE % | -27.7 | 3.7 |
| Net Margin % | -64.9 | 3.9 |
| Rev Growth 5Y % | 13.8 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.104
KWD 0.089 – KWD 0.118
|
700 M | 1 |
| FY2029 |
KWD 0.041
KWD 0.035 – KWD 0.046
|
530 M | 1 |
| FY2028 |
-KWD 0.017
-KWD 0.020 – -KWD 0.015
|
430 M | 1 |
النقاط الرئيسية
Revenue grew 13.76% annually over 5 years — strong growth
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -66.29M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.44%
Capital efficient — spends only 1.56% of revenue on capex
النمو
Revenue Growth (5Y)
13.76%
Revenue (1Y)22.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-27.66%
ROIC-23.07%
Net Margin-64.85%
Op. Margin-69.36%
الأمان
Debt / Equity
0.09
Current Ratio3.56
Interest Coverage-55.46
التقييم
P/E Ratio
-11.09
P/B Ratio3.48
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.20% | Revenue Growth (3Y) | 14.87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 223.86M | Net Income (TTM) | -145.18M |
| ROE | -27.66% | ROA | -23.33% |
| Gross Margin | 58.64% | Operating Margin | -69.36% |
| Net Margin | -64.85% | Free Cash Flow (TTM) | -66.29M |
| ROIC | -23.07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 3.56 |
| Interest Coverage | -55.46 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.09 | P/B Ratio | 3.48 |
| P/S Ratio | 7.19 | PEG Ratio | 1.35 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.61B | Enterprise Value | 1.47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 223.86M | 183.19M | 169.67M | 198.60M | 133.66M |
| Net Income | -145.18M | -146.19M | -154.51M | -91.03M | -167.61M |
| EPS (Diluted) | -0.15 | -0.16 | -0.19 | -0.11 | -0.20 |
| Gross Profit | 131.28M | 105.40M | 90.48M | 123.81M | 73.20M |
| Operating Income | -155.27M | -152.33M | -168.61M | -98.48M | -164.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 622.40M | 742.05M | 777.06M | 823.89M | 841.87M |
| Total Liabilities | 159.17M | 155.71M | 133.21M | 130.33M | 137.89M |
| Shareholders' Equity | 463.22M | 586.34M | 643.85M | 693.56M | 703.98M |
| Total Debt | 41.49M | 45.96M | 41.66M | 34.10M | 24.80M |
| Cash & Equivalents | 181.07M | 199.52M | 220.54M | 356.78M | 487.84M |
| Current Assets | 419.93M | 520.10M | 447.18M | 638.00M | 750.61M |
| Current Liabilities | 117.98M | 111.49M | 89.20M | 91.54M | 105.05M |